Evolution of COVID-19 antiviral interventions in Taiwan, 2022-2025: Insights from public health policy.

Paxlovid (nirmatrelvir/ritonavir) - Pfizer

Lagevrio (molnupiravir) - Ridgeback Biotherap, Merck (MSD)

remdesivir - Generic mfg.

http://www.ncbi.nlm.nih.gov/pubmed/42362430

Chien-Yu Lin; Chin-Hui Yang; Fu-Tien Lin; Hsin-Yi Wei; Shu-Ching Huang; Ya-Li Shih; Yu-Jing Lin

Jun 27, 2026